Perspective Therapeutics (CATX) Work In Process (2011 - 2023)
Perspective Therapeutics (CATX) posted Work In Process of $616000.0 for Q1 2023, down 3.14% sequentially from $636000.0 in Q4 2022, and up 73.52% YoY from $355000.0 in Q1 2022.
Perspective Therapeutics (CATX) Work In Process (2011 - 2023) Analysis & Trends
Perspective Therapeutics has reported Work In Process for 11 years, with the latest figure at $616000.0 in Q1 2023.
- Quarterly Work In Process rose 73.52% year-over-year to $616000.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $616000.0 (up 73.52% YoY) and the FY2022 annual result came in at $636000.0, changed N/A from the prior year.
- Work In Process fell to $616000.0 in Q1 2023 per CATX's latest filing, from $636000.0 in the prior quarter.
- Over five years, Work In Process peaked at $636000.0 in Q4 2022 and troughed at $114000.0 in Q1 2019.
- A 5-year average of $306000.0 and a median of $240000.0 in 2020 frame the typical range for Work In Process.
- The sharpest annual moves came in 2019 and 2022: Work In Process slipped 25.49% in 2019, then jumped 129.1% in 2022.
- Over 5 years, Work In Process stood at $166000.0 in 2019, then increased by 26.51% to $210000.0 in 2020, then surged by 37.14% to $288000.0 in 2021, then soared by 120.83% to $636000.0 in 2022, then retreated by 3.14% to $616000.0 in 2023.
- According to Business Quant data, Work In Process over the past three periods registered $616000.0, $636000.0, and $614000.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn |
| 10 | Perspective Therapeutics | 388.50 Mn | 388.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 616,000.00 |
| Dec 31, 2022 | 636,000.00 |
| Sep 30, 2022 | 614,000.00 |
| Jun 30, 2022 | 462,000.00 |
| Mar 31, 2022 | 355,000.00 |
| Dec 31, 2021 | 288,000.00 |
| Sep 30, 2021 | 268,000.00 |
| Jun 30, 2021 | 286,000.00 |
| Mar 31, 2021 | 201,000.00 |
| Dec 31, 2020 | 210,000.00 |
| Sep 30, 2020 | 240,000.00 |
| Jun 30, 2020 | 221,000.00 |
| Mar 31, 2020 | 198,000.00 |
| Dec 31, 2019 | 166,000.00 |
| Sep 30, 2019 | 161,000.00 |
| Jun 30, 2019 | 166,000.00 |
| Mar 31, 2019 | 114,000.00 |
| Dec 31, 2018 | 97,000.00 |
| Sep 30, 2018 | 102,000.00 |
| Jun 30, 2018 | 96,000.00 |